Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
Why this paper is included
Supporting source evidence:
Furthermore, these individuals were more likely to have elevated levels of vitamin D (p < 0.001) and magnesium (p = 0.014).
Source: Results. View original paper
Relevance classification does not establish study quality, causation or editorial approval.
Study design Cohort study.
Cohort study
Examines exposures and outcomes over time within a defined group.
Meta-analysis unclear · Blinding unclear / not reported · Human research reported
How this paper was classified
Automatic source-based classification; awaiting editorial verification. This is not a quality score.
Our retrospective cohort study included a total of 6,212 patients diagnosed with either EOAD or LOAD from February 2016 to August 2020.
Source: Abstract.
Patients were classified as having AD using a combination of cognitive and neurological testing (MOCA, MMSE, etc.) and brain imaging (MRI, MRA, CT, CTA, etc.).
Source: Methods.
What the study types mean
- Systematic review
- Uses explicit methods to identify, assess and summarise research on a defined question.
- Scoping review
- Maps the extent and characteristics of research on a topic.
- Narrative review
- Discusses existing research; systematic-review methods have not been established by this classification.
- Review / evidence synthesis
- Reviews existing research; the exact review methods need further assessment.
- Randomised controlled trial
- Assigns participants or groups to comparison interventions by chance.
- Non-randomised intervention study
- Examines an intervention without random allocation.
- Cohort study
- Examines exposures and outcomes over time within a defined group.
- Case-control study
- Compares people with an outcome against people without it, examining exposures.
- Cross-sectional study
- Examines a population at a particular point in time.
- Observational study
- Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
- Case report
- Describes an individual case.
- Case series
- Describes a group of individual cases.
- Secondary analysis
- Analyses existing study data; this paper is not automatically another independent trial.
- Laboratory study
- Investigates biological processes in a laboratory setting.
- Qualitative study
- Examines experiences or meanings using qualitative methods.
- Genetic instrumental-variable study
- Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
- Study protocol
- Describes planned methods and is not evidence that the planned study has reported results.
- Multiple reported designs
- More than one design is explicitly reported; examine the supporting methods.
- Study design awaiting verification
- The available source does not establish a sufficiently clear study design.
Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.
Abstracts
Sex differences in clinical risk factors for Alzheimer's dementia patients with early-onset and late-onset
Cohort study · Frontiers in Global Women's Health · 2025
Original publication title
Sex differences in clinical risk factors for Alzheimer's dementia patients with early-onset and late-onset
© 2025 Faulstich, Hilmi Omar, John O-brien, Ojo, Brewer, Nathaniel, Goodwin, Roley, Imeh-Nathaniel and Nathaniel.
Original publication · Publisher record · CC BY 4.0
Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.
At a glance
Abstract: What background does the paper provide?
The objective of this study is to identify the risk factors that contribute to sex differences in patients with Alzheimer dementia (AD), specifically focusing on Early-Onset Alzheimer's Dementia (EAOD) and Late-Onset Alzheimer Dementia (LOAD). Additionally, the study aims to determine whether these risk factors differ between male and female EAOD and LOAD patients.
Source: BackgroundAbstract: What methods does the paper describe?
Our retrospective cohort study included a total of 6,212 patients diagnosed with either EOAD or LOAD from February 2016 to August 2020. Among this population, 687 patients (11.06%) were diagnosed with EOAD, while 5,525 patients (88.94%) had LOAD. We conducted a univariate analysis to identify differences in risk factors between male and female AD patients. A multivariate analysis was also performed to predict specific risk factors associated with male and female EOAD and LOAD patients.
Source: MethodsAbstract: Results
In the adjusted analysis, males with LOAD were found to have significantly higher odds of several comorbidities, including dyslipidemia [Odds Ratio (OR) = 1.720, 95% Confidence Interval (CI) = 1.489 to 1.987, p < 0.001], peripheral vascular disease (OR = 2.324, 95% CI = 1.828 to 2.955, p < 0.001), obstructive sleep apnea (OR = 2.330, 95% CI = 1.768 to 3.070, p < 0.001), and pneumonia (OR = 1.235, 95% CI = 1.004 to 1.520, p = 0.046). In contrast, females with LOAD were associated with lower odds of having hypertension (OR = 0.715, 95% CI = 0.623 to 0.820, p < 0.001), osteoporosis (OR = 0.310, 95% CI = 0.254 to 0.380, p < 0.001), urinary tract infections (OR = 0.638, 95% CI = 0.521 to 0.782, p < 0.001), congestive heart failure (OR = 0.626, 95% CI = 0.481 to 0.815, p < 0.001), and rheumatoid arthritis.
In male patients with EAOD the analysis indicated a strong association with gait dysfunction (OR = 10.797, 95% CI = 3.257 to 35.792, p < 0.001), peripheral vascular disease (OR = 3.835, 95% CI = 1.767 to 8.321, p < 0.001), and Chronic Obstructive Pulmonary Disease (COPD) (OR = 5.984, 95% CI = 2.186 to 16.381, p < 0.001). Conversely, females with EOAD were associated with significantly lower odds of experiencing cerebrovascular accidents (OR = 0.347, 95% CI = 0.155 to 0.778, p < 0.001), osteoporosis (OR = 0.345, 95% CI = 0.155 to 0.778, p = 0.030), and anxiety (OR = 0.412, 95% CI = 0.203 to 0.833, p = 0.014).
Source: ResultsAbstract: Conclusions
Our findings indicate sex differences in the risk factors for EAOD and LOAD patients. Understanding these risk factors can help us develop strategies to improve diagnostic accuracy, create targeted interventions, and enhance clinical outcomes for both male and female EAOD and LOAD patients.
Source: ConclusionsAuthors’ abstract
Background
The objective of this study is to identify the risk factors that contribute to sex differences in patients with Alzheimer dementia (AD), specifically focusing on Early-Onset Alzheimer's Dementia (EAOD) and Late-Onset Alzheimer Dementia (LOAD). Additionally, the study aims to determine whether these risk factors differ between male and female EAOD and LOAD patients.
Methods
Our retrospective cohort study included a total of 6,212 patients diagnosed with either EOAD or LOAD from February 2016 to August 2020. Among this population, 687 patients (11.06%) were diagnosed with EOAD, while 5,525 patients (88.94%) had LOAD. We conducted a univariate analysis to identify differences in risk factors between male and female AD patients. A multivariate analysis was also performed to predict specific risk factors associated with male and female EOAD and LOAD patients.
Results
In the adjusted analysis, males with LOAD were found to have significantly higher odds of several comorbidities, including dyslipidemia [Odds Ratio (OR) = 1.720, 95% Confidence Interval (CI) = 1.489 to 1.987, p < 0.001], peripheral vascular disease (OR = 2.324, 95% CI = 1.828 to 2.955, p < 0.001), obstructive sleep apnea (OR = 2.330, 95% CI = 1.768 to 3.070, p < 0.001), and pneumonia (OR = 1.235, 95% CI = 1.004 to 1.520, p = 0.046). In contrast, females with LOAD were associated with lower odds of having hypertension (OR = 0.715, 95% CI = 0.623 to 0.820, p < 0.001), osteoporosis (OR = 0.310, 95% CI = 0.254 to 0.380, p < 0.001), urinary tract infections (OR = 0.638, 95% CI = 0.521 to 0.782, p < 0.001), congestive heart failure (OR = 0.626, 95% CI = 0.481 to 0.815, p < 0.001), and rheumatoid arthritis.
In male patients with EAOD the analysis indicated a strong association with gait dysfunction (OR = 10.797, 95% CI = 3.257 to 35.792, p < 0.001), peripheral vascular disease (OR = 3.835, 95% CI = 1.767 to 8.321, p < 0.001), and Chronic Obstructive Pulmonary Disease (COPD) (OR = 5.984, 95% CI = 2.186 to 16.381, p < 0.001). Conversely, females with EOAD were associated with significantly lower odds of experiencing cerebrovascular accidents (OR = 0.347, 95% CI = 0.155 to 0.778, p < 0.001), osteoporosis (OR = 0.345, 95% CI = 0.155 to 0.778, p = 0.030), and anxiety (OR = 0.412, 95% CI = 0.203 to 0.833, p = 0.014).
Conclusions
Our findings indicate sex differences in the risk factors for EAOD and LOAD patients. Understanding these risk factors can help us develop strategies to improve diagnostic accuracy, create targeted interventions, and enhance clinical outcomes for both male and female EAOD and LOAD patients.
Publication and source details
Original title: Sex differences in clinical risk factors for Alzheimer's dementia patients with early-onset and late-onset
Nathan Gerhard Faulstich; Sammy Hilmi Omar; Connor John O-brien; Dami Taiwo Ojo; Philip Cole Brewer; Emmanuel I. Nathaniel; Richard Goodwin; Laurie Roley; Adebobola Imeh-Nathaniel; Thomas I. Nathaniel
Frontiers in Global Women's Health · 2025
Edited by: Xiaohui Sem, Women in Global Health Singapore, Singapore
Reviewed by: Roberta Marongiu, Cornell University, United States
Cecilia Boccalini, University of Geneva, Switzerland
Repository JATS snapshot; version as supplied
Source retrieved: 2026-11-11T03:37:28.340773+00:00
DOI: 10.3389/fgwh.2025.1601375 · PMC12358484